Vitamin D Deficiency Diagnostic Assay Market Type (1, 25-Dihydroxy Vitamin D Test, 25-Hydroxy Vitamin D Test), End-user (Hospitals, Research Centers, Diagnostic Centers) and Geography  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Vitamin D Deficiency Diagnostic Assay Market size was valued at USD 812.2 million in 2021, growing at a CAGR of 4.8% during the forecast period 2022-28. Vitamin D is a steroidal hormone that requires multiple metabolic steps to become active and useful in human body. Vitamin D can be found in several sources such as fish, eggs and sunlight.  Vitamin D deficiency causes rickets in children and will precipitate and exacerbate osteopenia, osteoporosis and fractures in adults. Vitamin D deficiency has been associated with increased risk of common cancers, autoimmune diseases, hypertension and infectious diseases. Vitamin D is known for its role in mineralization of teeth and bones through regulation of calcium and phosphorous hemostasis. Recently, there is emerging evidence of role of vitamin D in protection against risk for malignant neoplasms, cardiac diseases, diabetes along with osteoporosis and other bone disorders.  Vitamin d deficiency diagnostic assay market is saturated with many number of market players, hence companies are focusing on strategic such as agreements, partnerships, collaborations to survive in the market. Companies are also actively concentrating on collaborations with the governments, hospitals and research laboratories to raise funds for development of advanced products. For example, in 2014 Roche invested 450 Mn to build a new diagnostic equipment manufacturing unit in china and expected to commence the operation in 2018 to capture the market in Asia Pacific especially in China.

Vitamin D Deficiency Diagnostic Assay Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Drivers And Restraints

Increase in geriatric population coupled with increase in chronic illnesses, rising risk inn development of vitamin D deficiency includes pregnant and breast feeding women, teenagers, infants and children are anticipated to drive the market growth of vitamin d deficiency diagnostic assay market globally. Moreover, growing investments on R&D activities, approval and commercialization of new tests, geographical expansions by the market players and initiatives taken by the governments also propels the market growth of vitamin d deficiency diagnostic assay. However, unavailability of the tests in some regions, dearth of skilled workforce, lack of awareness regarding the tests and high cost associated with the diagnosis may hinder the growth the vitamin d deficiency diagnostic assay market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Vitamin D Deficiency Diagnostic Assay Market Segmentation

on the type
  • 1, 25-Dihydroxy Vitamin D Test
  • 25-Hydroxy Vitamin D Test
end user
  • Hospitals
  • Research Centers
  • Diagnostic Centers
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • DiaSorin S.p.A. (Italy)
  • Abbott Laboratories (U.S.)
  • Siemens Corporation (Germany)
  • Hologic, Inc, (U.S)
  • Quest Diagnostics, Inc. (U.S)
  • Danaher Corporation (U.S.)
  • bioMérieux SA (France)